Peptides & Research Chemicals
GHRP-6 (Growth Hormone Releasing Peptide)
Street names: ghrp-6, GHRP-2, hexarelin, growth hormone peptides
Overdose? Act now. Call emergency services — say "unresponsive, not breathing". Give naloxone for opioid-like signs. Hotlines
⚡What it does
- Stimulates the body's own growth hormone release
- Strong hunger shortly after injection (exploited for weight gain)
- Improved recovery claims
⚠Key risks
- No approved human use — long-term safety unknown
- Intense hunger can drive uncontrolled eating
- Raises cortisol and prolactin at higher doses
- Injection risks from grey-market products (sterility unknown)
- Banned by WADA
✚Overdose signs
- Flushing
- Racing heart
- Dizziness
- Severe hunger
- Water retention
Category comparison — Peptides & Research Chemicals
| Substance | Class | Top risks | Street price |
|---|---|---|---|
| GHRP-6 (Growth Hormone Releasing Peptide) | Unapproved; banned in sport | No approved human use — long-term safety unknown; Intense hunger can drive uncontrolled eating | €30-60 per vial from online peptide shops. |
| BPC-157 | Unscheduled — 'research chemical', not approved for human use anywhere | ZERO human clinical trials — all human use is anecdotal self-experimentation; Unregulated synthesis: purity, sterility, and actual content unverified | ~$20–$60 per 5 mg vial grey-market |
| TB-500 (Thymosin Beta-4 fragment) | Unscheduled — 'research chemical'; banned in sport | No approved human use or trials — same self-experimentation class as BPC-157; Growth/repair factor activity raises theoretical cancer concerns | ~$25–$70 per vial grey-market |
| Melanotan II | Unscheduled | Unapproved — regulators (FDA/TGA/MHRA) have issued warnings and seizures; 'Melanotan rage' — documented mood/aggression changes | ~$20–$50 per 10 mg vial grey-market |
| GHRPs & GH Secretagogues | Unscheduled — 'research chemicals' | All are 'research chemical' grade unless pharmacy-sourced: purity unknown; Water retention, carpal-tunnel symptoms, insulin resistance with chronic use | ~$15–$40 per vial grey-market |
| IGF-1 & MGF analogues | Unscheduled — 'research chemicals'; IGF-1 is Rx | Hypoglycemia — IGF-1 pulls blood sugar down hard; dangerous in diabetics; Theoretical but serious cancer concerns — IGF-1 feeds tumor growth | ~$30–$80 per vial grey-market |
Street prices are regional estimates. Potency and cuts vary constantly.
?Frequently asked questions
What does GHRP-6 (Growth Hormone Releasing Peptide) look like?
Lyophilised powder in vials, reconstituted and injected; sold by grey-market peptide vendors.
What are the signs of a GHRP-6 (Growth Hormone Releasing Peptide) overdose?
Flushing; Racing heart; Dizziness Call emergency services immediately.
How addictive is it?
No approved human use — long-term safety unknown Dependence can develop with regular use.